Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biolog Announces Appointment of Distributors in Europe

Published: Thursday, September 27, 2012
Last Updated: Thursday, September 27, 2012
Bookmark and Share
New distributors to cover sales and marketing of Biolog’s innovative product lines.

New distributors were announced by Biolog, Inc. to cover sales and marketing of its innovative product lines for characterization and identification of diverse cell types, from bacteria to human cells.

The distributors and their respective territories are IUL Instruments GmbH, Koningswinter, Germany (Germany and Austria), Awel International, Blain, France (France), A&LCO Industries, Cologno, Italy (Italy), and IUL S.A., Barcelona, Spain (Spain).

According to Barry Bochner, CEO & CSO at Biolog, "The distributors were selected as being most qualified to provide local supply, technical and service support to our customers in these countries."

Biolog's flagship product is the GEN III MicroPlate™, a test panel that can be used for identifying over 1,300 species of bacteria and covering human pathogens, animal pathogens, plant pathogens, and typical environmental bacteria.

Phenotype MicroArrays™, the company's most advanced product line, have diverse applications ranging from basic genetic and cellular research to cancer studies, drug and toxicology studies, and bioprocess optimization.

Biolog's product lines also include advanced instrumented systems such as the OmniLog® and MicroStation™ that automatically read and help to interpret the phenotypic data that is generated.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biolog’s PM Technology Unlocks Critical Clue in Understanding Autism
Discovery demonstrates advantage of metabolic over genetic screening.
Friday, June 07, 2013
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!